National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 59145-59146 [2011-24508]
Download as PDF
Federal Register / Vol. 76, No. 185 / Friday, September 23, 2011 / Notices
sroberts on DSK5SPTVN1PROD with NOTICES
practitioners in the NPDB. Unlike a
traditional query, PDS enrolled
practitioners are continuously
monitored and subscribed entities need
not pay for multiple queries each time
they want to access new information on
a practitioner. The following table
charts the growth of PDS enrollments
beginning in June 2007 through June
2010 for the NPDB and the HIPDB:
Reduction Act of 1995, the National
Institute of Nursing (NINR), the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This information
collection was previously published in
the Federal Register on June 16, 2011,
page 35221 and allowed 60 days for
public comment. No public comments
NUMBER OF PRACTITIONERS ENROLLED were received. The purpose of this
IN PDS
notice is to allow an additional 30 days
for public comment.
Month/year
NPDB
HIPDB
5 CFR 1320.5 (General requirements)
Reporting and Recordkeeping
June 2010 .............
481,794
125,649
June 2009 .............
311,275
101,720 Requirements: Final Rule requires that
June 2008 .............
113,631
12,592 the agency inform the potential persons
June 2007 .............
47,641
2,005 who are to respond to the collection of
information that such persons are not
The number of enrollments is steadily required to respond to the collection of
climbing and re-enrollment rates for this information unless it displays a
service are approximately 90 percent.
currently valid OMB control number.
This service is quickly becoming the
This information is required to be stated
benchmark for monitoring practitioner
in the 30-day Federal Register Notice.
credentials because it is designed and
Proposed Collection: Title: NINR Enddeveloped to meet new accreditation
of-Life and Palliative Care Science
standards that require on-going
Needs Assessment: Funding Source
monitoring of practitioners. In light of
(Survey of Authors). Type of
these developments, HRSA is making
Information Collection Request: NEW.
this service a permanent feature. The
Need and Use of Information Collection:
name change from PDS to Continuous
The NINR End-of-Life Science Palliative
Query better captures the true nature of
Care (EOL PC) Needs Assessment:
this service, which is the continuous
Funding Source Questionnaire will
monitoring of enrolled practitioners.
obtain information on funding sources
All aspects of the PDS querying
of EOL PC research published studies
service as described in the March 7,
for which a funding source is not cited
2007 notice are still in effect except for
or the information is unclear. Target
the upgrade from prototype to
participants are authors of publiclypermanent status and the name change
available EOL PC research studies
set forth in this notice.
published between 1997–2010 for
whom a funding source is unknown or
II. Revisions to Previous Notice
unclear. The questionnaire inquires
This notice is to inform the public
about the funding source of the
that the prototype status for PDS is
published study, type of funding
removed and that the name of the PDS
received, year of funding, and duration
querying service has been changed to
of funded study. This is a 7-item
Continuous Query.
questionnaire that takes approximately
Dated: September 16, 2011.
5 minutes to complete. Data collected is
Mary K. Wakefield,
part of a needs assessment to address
Administrator, Health Resources and Services the breadth and depth of EOL PC
Administration.
scientific issues for use in stimulating
[FR Doc. 2011–24403 Filed 9–22–11; 8:45 am]
research capacity in the field. Frequency
of Response: One time. Affected Public:
BILLING CODE 4165–15–P
Individual authors of publicly available
EOL PC research publications who do
DEPARTMENT OF HEALTH AND
not list a funding source or the source
HUMAN SERVICES
is unclear within their publication. Type
of Respondents: EOL PC researchers.
National Institutes of Health
The annual reporting burden is as
follows: Estimated Number of
Submission for OMB Review;
Respondents: 1840; Estimated Number
Comment Request; NINR End-of-Life
of Responses per Respondent: 1;
and Palliative Care Science Needs
Average Burden Hours Per Response:
Assessment: Funding Source (Survey
.08; and Estimated Total Annual Burden
of Authors)
Hours Requested: 147. There are no
Summary: Under the provisions of
Capital Costs, Operating or Maintenance
Section 3507(a)(1)(D) of the Paperwork
Costs to report.
VerDate Mar<15>2010
16:41 Sep 22, 2011
Jkt 223001
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
59145
Request for comments: Written
comments and/or suggestions from the
public and affected agencies should
address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Direct comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974, Attention: Desk
Officer for NIH. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and instruments, contact: Dr.
Amanda Greene, Office of Science
Policy and Public Liaison, NINR, NIH,
Democracy One, 6701 Democracy Blvd.,
Suite 710, Bethesda, MD 20892 or call
non-toll-free number (301) 496–9601 or
E-mail your request, including your
address to: amanda.greene@nih.gov.
Comments due date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30-days of the date of
this publication.
Dated: September 16, 2011.
Amanda Greene,
Science Evaluation Officer, NINR, National
Institutes of Health.
[FR Doc. 2011–24510 Filed 9–22–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\23SEN1.SGM
23SEN1
59146
Federal Register / Vol. 76, No. 185 / Friday, September 23, 2011 / Notices
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
sroberts on DSK5SPTVN1PROD with NOTICES
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, NIDDK STEP–UP
(R25).
Date: November 15, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Legacy Hotel and Meeting Centre,
1775 Rockville Pike, Rockville, MD 20852.
Contact Person: Ann A. Jerkins, PhD,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 759, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, 301–594–2242,
jerkinsa@niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, NIDDK Member
Conflicts SEP.
Date: November 28, 2011.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Xiaodu Guo, MD, PhD,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 761, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–4719,
guox@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: September 19, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–24508 Filed 9–22–11; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
16:41 Sep 22, 2011
Jkt 223001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Advisory Committee on Research on
Women’s Health.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Advisory Committee
on Research on Women’s Health.
Date: October 20–21, 2011.
Time: 9 a.m. to 12 p.m.
Agenda: The purpose of the meeting will
be for the Committee to provide advice to the
Office of Research on Women’s Health
(ORWH) on appropriate research activities
with respect to women’s health and related
studies to be undertaken by the national
research institutes; to provide
recommendations regarding ORWH
activities; to meet the mandates of the office;
and for discussion of scientific issues.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Joyce Rudick, Director,
Programs & Management, Office of Research
on Women’s Health, Office of the Director,
National Institutes of Health, Building 1,
Room 201, Bethesda, MD 20892, 301/402–
1770.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
www4.od.nih.gov/orwh/, where an agenda
and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Dated: September 19, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–24505 Filed 9–22–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Clinical and
Translational Imaging Applications.
Date: October 17, 2011.
Time: 10 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Antonio Sastre, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5215,
MSC 7412, Bethesda, MD 20892, 301–435–
2592, sastrea@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Risk,
Prevention and Intervention for Addictions:
Overflow.
Date: October 21, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza Hotel—Silver Spring,
8777 Georgia Avenue, Silver Spring, MD
20910.
Contact Person: Kristen Prentice, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3112,
MSC 7808, Bethesda, MD 20892, 301–496–
0726, prenticekj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
E:\FR\FM\23SEN1.SGM
23SEN1
Agencies
[Federal Register Volume 76, Number 185 (Friday, September 23, 2011)]
[Notices]
[Pages 59145-59146]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-24508]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
[[Page 59146]]
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel, NIDDK STEP-UP (R25).
Date: November 15, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Legacy Hotel and Meeting Centre, 1775 Rockville Pike,
Rockville, MD 20852.
Contact Person: Ann A. Jerkins, PhD, Scientific Review Officer,
Review Branch, DEA, NIDDK, National Institutes of Health, Room 759,
6707 Democracy Boulevard, Bethesda, MD 20892-5452, 301-594-2242,
jerkinsa@niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel, NIDDK Member Conflicts
SEP.
Date: November 28, 2011.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Xiaodu Guo, MD, PhD, Scientific Review Officer,
Review Branch, DEA, NIDDK, National Institutes of Health, Room 761,
6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-4719,
guox@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: September 19, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-24508 Filed 9-22-11; 8:45 am]
BILLING CODE 4140-01-P